Estrogen and Alzheimer’s Disease: Neurobiology, Epigenetics, and AI-Driven Therapeutic Design
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, and women are disproportionately affected. This review examines the evidence that estrogen signaling contributes to this disparity and asks what a molecularly targeted therapeutic would require. We first distinguish prevalence from incidence in the g...
Tian-Hua Zhai, Risa Garg, Pei-Ming Li et al.
· Journal of Dementia and Alzh... · 0 citations